NCCN 2018 Congress Webinar Series: Breast Cancer

Breast cancer continues to be the second most common cause of cancer death in women in the United States.  The treatment of breast cancer is rapidly evolving.  Results from numerous clinical trials continue to expand new therapeutic options, treatment and risk reduction strategies, and diagnostic/prognostic tools.  Healthcare professionals need to be educated on current and emerging scientific data to make evidence-based treatment decisions and to provide optimal care for patients with breast cancer.  The NCCN 2018 Congress Webinar Series: Breast Cancer with Updates from the 2017 San Antonio Breast Cancer Symposium will provide expert insights on the current standard of care for patients with breast cancer and include the latest clinical research updates from the 2017 SABCS to assist clinicians in formulating breast cancer management strategies.

The goal of this project is to ensure that members of a multidisciplinary team, including physicians, nurses, pharmacists and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with breast cancer.

Target Audience

This educational program is designed to meet the educational needs of physicians, nurses, pharmacists, and other healthcare professionals who manage patients with breast cancer.

Learning Objectives

Following these activities, participants should be able to:

Adjuvant and Neoadjuvant Therapies, Including SABCS Updates (2/27/2018)

  • Recognize key patient and clinical factors that influence selection of systemic neoadjuvant and adjuvant treatment.
  • Discuss clinical data of new and emerging systemic therapy options with patients with early stage breast cancer.

Adjuvant Radiation Therapy in Early Stage Breast Cancer (3/7/2018)

  • Summarize recommendations based on tumor margin status after breast conservation for DCIS and early-stage invasive breast cancer.
  • Review recent NCCN Guidelines® updates to radiation therapy recommendations for DCIS and early-stage invasive breast cancer.

Role of Biomarkers and Molecular Assays in the Management of Breast Cancer (3/9/2018)

  • Compare the benefits and limitations of available multigene assays and determine their effectiveness in assessment of risk of recurrence.
  • Select the appropriate assay to individualize adjuvant systemic therapy recommendations.

Surgical Management of the Axilla in Early Stage Breast Cancer, Including SABCS Updates (3/13/2018)

  • Individualize the surgical management of the axilla using an evidence-based approach.
  • Discuss new and emerging data for surgical treatment of patients with early stage breast cancer.

Breast Cancer Screening (4/6/2018)

  • Outline the risks and benefits of routine screening with mammography in women between the ages of 40 to 49.
  • Discuss screening recommendations for women with high risk of developing breast cancer.

Management of Metastatic Breast Cancer, Including SABCS Updates (4/12/2018)

  • Select evidence-based treatment options for patients with advanced breast cancer based on hormone and HER2 receptor status.
  • Outline new and emerging therapeutic options for patients with advanced breast cancer.

Surveillance of Patients with Early Stage and Advanced Disease (5/3/2018)

  • Optimize the various strategies used for surveillance and follow-up after primary treatment in patients with early stage breast cancer.
  • Order appropriate tests to assess response to treatment in patients with metastatic disease.

Barriers to the Coordination of Cancer Care (5/17/2018)

  • Recognize common barriers encountered during planning and delivery of care for patients with breast cancer.
  • Counsel patients with breast cancer about the roles and responsibilities of the individuals in their multidisciplinary care team.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • Eisai
  • Genomic Health, Inc.
  • Lilly
  • Novartis
  • Pfizer
Course summary
Course opens: 
01/29/2018
Course expires: 
05/19/2018
Cost:
$0.00

Adjuvant and Neoadjuvant Therapies, Including SABCS Updates
Tuesday, February 27, 2018 • 4:30 - 5:30 PM EST
Lisa E. Flaum, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Lee S. Schwartzberg, MD, The University of Tennessee Health Science Center

NCCN Guidelines® Updates: Early Stage Breast Cancer
Wednesday, March 7, 2018 • 3:00 - 3:45 PM EST
Meena S. Moran, MD, Yale Cancer Center/Smilow Cancer Hospital

Role of Biomarkers and Molecular Assays in the Management of Breast Cancer
Friday, March 9, 2018 • 1:30 - 2:30 PM EST
Matthew P. Goetz, MD, Mayo Clinic Cancer Center

Surgical Management of the Axilla in Early Stage Breast Cancer, Including SABCS Updates
Tuesday, March 13, 2018 • 12:30 - 1:15 PM EDT
Benjamin O. Anderson, MD, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Breast Cancer Screening
Friday, April 6, 2018 • 12:00 - 12:45 PM EDT
Therese B. Bevers, MD, The University of Texas MD Anderson Cancer Center

Management of Metastatic Breast Cancer, Including SABCS Updates
Thursday, April 12, 2018 • 2:00 - 3:00 PM EDT
William J. Gradishar, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Surveillance of Patients with Early Stage and Advanced Disease
Thursday, May 3, 2018 • 2:00 - 2:45 PM EDT
Harold J. Burstein, MD, PhD, Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center

Barriers to the Coordination of Cancer Care
Thursday, May 17, 2018 • 3:30 - 4:15 PM EDT
Julia R. Trosman, PhD, MBA, Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Feinberg School of Medicine, Northwestern University; Center for Business Models in Healthcare

ALL WEBINAR TIMES ARE POSTED AS EASTERN STANDARD TIME (EST) (UTC/GMT -5:00) OR EASTERN DAYLIGHT TIME (EDT) (UTC/GMT -4:00).

Access to participate in selected sessions is through the NCCN WebEx Site on the day of each scheduled program.

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Physicians
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NCCN designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Medical Specialties (MOC)
Through the American Board of Medical Specialties (“ABMS”) MOC Initiative to create a wide array of Maintenance of Certification (“MOC”) Activities through the ABMS MOC Directory, NCCN 2018 Congress Webinar Series: Breast Cancer has met the MOC requirements as a MOC Part II CME Activity (apply toward general CME requirement) by the following ABMS Member Boards:

MOC Part II CME Activity
Pathology
Radiology

Note: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement (only). Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 6.75 hours of Category 1 credits for completing this activity.

Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 6.75 contact hours.

Pharmacists

National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

NCCN designates this knowledge-based continuing education activity for 6.75 contact hours (0.675 CEUs) of continuing education credit.

Adjuvant and Neoadjuvant Therapies, Including SABCS Updates
Tuesday, February 27, 2018 • 4:30 - 5:30 PM EST
1.0 contact hour (0.1 CEUs)
UAN: 0836-0000-18-022-L01-P

Adjuvant Radiation Therapy in Early Stage Breast Cancer
Wednesday, March 7, 2018 • 3:00 - 3:45 PM EST
0.75 contact hour (0.075 CEU)
UAN: 0836-0000-18-023-L01-P

Role of Biomarkers and Molecular Assays in the Management of Breast Cancer
Friday, March 9, 2018 • 1:30 - 2:30 PM EST
1.0 contact hour (0.1 CEUs)
UAN: 0836-0000-18-024-L01-P

Surgical Management of the Axilla in Early Stage Breast Cancer, Including SABCS Updates
Tuesday, March 13, 2018 • 12:30 - 1:15 PM EDT
0.75 contact hour (0.075 CEU)
UAN: 0836-0000-18-025-L01-P

Breast Cancer Screening
Friday, April 6, 2018 • 12:00 - 12:45 PM EDT
0.75 contact hour (0.075 CEU)
UAN: 0836-0000-18-026-L01-P

Management of Metastatic Breast Cancer, Including SABCS Updates
Thursday, April 12, 2018 • 2:00 - 3:00 PM EDT
1.0 contact hour (0.1 CEUs)
UAN: 0836-0000-18-027-L01-P

Surveillance of Patients with Early Stage and Advanced Disease
Thursday, May 3, 2018 • 2:00 - 2:45 PM EDT
0.75 contact hour (0.075 CEU)
UAN: 0836-0000-18-028-L01-P

Barriers to the Coordination of Cancer Care
Thursday, May 17, 2017 • 3:30 - 4:15 PM EDT
0.75 contact hour (0.075 CEU)
UAN: 0836-0000-18-029-L01-P

Available Credit

Accreditation Period

Course opens: 
01/29/2018
Course expires: 
05/19/2018
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.

Please refer to the Schedule tab for dates and times.  Check the webinars you would like to attend and click Enroll.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing